SEC Form 4 · accession 0001209191-17-021747
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ralf Ledda
Officer — Sen VP/GM-EUR,Mid East&Africa
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Mar 16, 2017 | A | 7,296 | $0.00 | A | 32,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3,F4 | — | holding | — | — | — | — | — | Common Shares | 14,500 | 14,500 | D |
Explanation of responses
- F1Restricted stock units granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2018.
- F2Includes 24,800 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 1,000 of these restricted stock units vest in full on May 15, 2017 after a three-year "cliff" vesting period; 800 of these restricted stock units vest in 1/2 increments on May 15, 2017 and May 15, 2018; 3,000 of these restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2017; and 20,000 of these restricted stock units vest in full on November 15, 2019 after a three-year "cliff" vesting period.
- F3No transaction is being reported on this line. Reported on a previously filed Form 3 or Form 5.
- F4The reporting person holds previously reported options to buy 14,500 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 22, 2007 and March 18, 2013, at exercise prices between $13.37 to $25.79 per share, will expire between August 22, 2017 and March 18, 2023, and became or will become exercisable between September 30, 2008 and March 31, 2017.